使用肺量计筛查慢性阻塞性肺疾病：美国预防服务工作组建议声明。
Screening for chronic obstructive pulmonary disease using spirometry: U.S. Preventive Services Task Force recommendation statement.
机构信息
U.S. Preventive Services Task Force, Agency for Healthcare Research and Quality, Rockville, Maryland, USA.
出版信息
Ann Intern Med. 2008 Apr 1;148(7):529-34. doi: 10.7326/0003-4819-148-7-200804010-00212. Epub 2008 Mar 3.
DESCRIPTION
New U.S. Preventive Services Task Force (USPSTF) recommendation about screening for chronic obstructive pulmonary disease (COPD) using spirometry.
METHODS
The USPSTF weighed the benefits (prevention of > or =1 exacerbation and improvement in respiratory-related health status measures) and harms (time and effort required by both patients and the health care system, false-positive screening tests, and adverse effects of subsequent unnecessary therapy) of COPD screening identified in the accompanying review of the evidence. The USPSTF did not consider the financial costs of spirometry testing or COPD therapies.
RECOMMENDATION
Do not screen adults for COPD using spirometry. (Grade D recommendation).
描述
美国预防服务工作组（USPSTF）关于使用肺活量测定法筛查慢性阻塞性肺疾病（COPD）的新建议。
方法
USPSTF权衡了在随附的证据综述中确定的COPD筛查的益处（预防≥1次加重以及改善呼吸相关健康状况指标）和危害（患者和医疗保健系统所需的时间和精力、筛查试验假阳性以及后续不必要治疗的不良反应）。USPSTF未考虑肺活量测定测试或COPD治疗的财务成本。
建议
不要使用肺活量测定法对成年人进行COPD筛查。（D级建议）
Zotero 插件